What Can Dead People Tell Us? Postmortem Toxicology for Attorneys

Size: px
Start display at page:

Download "What Can Dead People Tell Us? Postmortem Toxicology for Attorneys"

Transcription

1 What Can Dead People Tell Us? Postmortem Toxicology for Attorneys Dr. Allison A. Muller Diplomate, American Board of Applied Toxicology Principal/Owner: Acri Muller Consulting, LLC Learning objectives List 3 things that happen to the body after death that relate to drugs Define the terms pharmacokinetics and pharmacodynamics Explain one way that postmortem changes affect drug levels State one example of how a drug level cannot be tied to a cause of death State one example of how a drug level can be tied to a cause of death 2 1

2 First some definitions Pharmacokinetics 3 First some definitions Pharmacodynamics 4 2

3 First some definitions Volume of distribution 5 First some definitions Lipophilicity 6 3

4 Changes to the body after death 7 Postmortem redistribution (PMR) the basics 8 4

5 Sources of drug levels Vitreous humor Urine Bile Tissue Blood Femoral Heart May be ante mortem (hospital blood) 9 Example of test results Detailed Findings: Analysis and Comments Result Units Rpt. Limit Specimen Source Analysis By Caffeine Positive mcg/ml Hospital Blood LC/TOF MS Nicotine Positive ng/ml Hospital Blood LC/TOF MS Amphetamine 66 ng/ml Hospital Blood LC MS/MS Methamphetamine 180 ng/ml Hospital Blood LC MS/MS Other than the above findings, examination of the specimen(s) submitted did not reveal any positive findings of toxicological significance by procedures outlined in the accompanying Analysis Summary. 10 5

6 Units of measurement Weight Abbreviation Conversion Factor Gram G 1 g = 1000 mg Milligram mg 1 mg = 1000 mcg = g Microgram Mcg 1 mcg = mg = g Kilogram Kg 1 kg = 1000 g 11 Know the menu for toxicology testing 12 6

7 Example of test results Analysis Summary of Reporting Limits: All of the following tests were performed for this case. For each test, the compounds listed were included in the scope. The Reporting Limit listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present Acode 52409B Amphetamines Confirmation, Blood (Forensic) Hospital Blood Analysis by High Performance Liquid Chromatography/TandemMass Spectrometry (LC MS/MS) for: Compound Amphetamine Ephedrine MDA MDEA Methamphetamine Norpseudoephedrine Rpt Limit 10 ng/ml Compound Phendimetrzine Phenmetrazine Phentermine Phenylpropanolamine Pseudoephedrine Rpt Limit 10 ng/ml 10 ng/ml Acode 8062B Postmortem Toxicology Expanded w/o Alcohol, Blood (Forensic) Hospital Blood Analysis by Enzyme Linked Immunosorbent Assay (ELISA) for: Compound Barbiturates Rpt Limit ng/ml Compound Cannabinoids Rpt Limit 10 ng/ml 13 Drug levels and cause of death: a link? Simple, right? Compare levels to a table and voila! Therapeutic vs. toxic vs. lethal levels 14 7

8 Interpreting toxicology lab reports Minimum threshold Therapeutic versus toxic ranges 15 Pitfalls when interpreting drug levels postmortem Site of sampling Time of sampling PMR Referring to lists of lethal concentrations Trauma 16 8

9 Details needed to assess postmortem case Medical/ drug history Autopsy Death scene evidence Tox/lab reports 17 Heroin postmortem 18 9

10 Fentanyl postmortem 19 Ethanol postmortem 20 10

11 Case example (1) Patient prescribed fentanyl patch for pain Opioid naïve patient No patches found on body at autopsy Levels of fentanyl postmortem deemed to be in lethal range Cause of death related to this prescription opioid pain patch? 21 Case example (2) Woman found dead following an auto accident Was in car underwater for several days before being found History of drug abuse. In addiction treatment Heroin metabolites found postmortem Syringes found in car Was she high at the time of the accident? 22 11

12 Case example (3) Man was sold heroin at 7 pm Found dead in his home at 12 midnight Toxicology findings: heroin metabolites, diazepam, methamphetamine Was the death due to the drug he was sold at 7 pm? 23 Case example(4) Man has a negative ( ) postmortem toxicology screen for opiates but has a history of oxycodone use for chronic pain 24 12

13 Allison A. Muller, PharmD, Diplomate American Board of Applied Toxicology (215)

An Introduction to Forensic Toxicology

An Introduction to Forensic Toxicology An Introduction to Forensic Toxicology Jennifer Shea, PhD, FCACB Ken Obenson, MBBS MFFLM (UK) FRCPC (Anat) FRCPC (Forensic Path) Dip American Brd of Path (Anat & Clin/Cytopath/Forensic Path) April 11,

More information

All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy. (Paraclesus, )

All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy. (Paraclesus, ) All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy (Paraclesus, 1493-1541) Discussion Questions About Paraclesus Quote 1. Do you agree

More information

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch

More information

Tests recently added to the NMS Labs test menu. New Tests are effective immediately.

Tests recently added to the NMS Labs test menu. New Tests are effective immediately. Immediate Action In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed

More information

Tests recently added to the NMS Labs test menu. New Tests are effective immediately.

Tests recently added to the NMS Labs test menu. New Tests are effective immediately. Immediate Action In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed

More information

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Patient Rx Drug Misuse and Abuse: Compliance Toxicology Monitoring in Clinical Practice Toxicology Staff Andrea Terrell, Ph.D., DABCC Chief Scientific Officer George Behonick, Ph.D., DABFT, Manager, FBU

More information

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly Utilization of the urine drug screen: The good, the bad, and the ugly Jennifer A. Lowry, MD Chief, Section of Medical Toxicology Children s Mercy Hospital Kansas City, MO Learning Objectives Describe the

More information

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,

More information

DRUG - RELATED DEATH

DRUG - RELATED DEATH DRUG - RELATED DEATH Lithuania EVELINA PRIDOTKIENĖ D R U G, TA B A C C O A N D A L C O H O L C O N T R O L D E PA R T M E N T H E A D OF N AT I O N A L F O C A L P O I N T Background: Since 2010 data on

More information

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements. In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed below are the

More information

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016 Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 04/10/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

Forensic Toxicology. William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont

Forensic Toxicology. William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont Forensic Toxicology William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont History of Forensic Toxicology Paracelsus (1493-1541) 1541) Orfila (1787-1853)

More information

Urine Drug Testing Methods 3-5

Urine Drug Testing Methods 3-5 Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry

More information

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Controlled Substance Monitoring in the Age of the Opioid Epidemic Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,

More information

Cutoff levels for hydrocodone in a blood test

Cutoff levels for hydrocodone in a blood test Cutoff levels for hydrocodone in a blood test The premier DNA and drug testing company in the North Texas area. Specializing in legal cases but also provide testing for employers and private individuals.

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

MEDICAL POLICY No R2 DRUG TESTING

MEDICAL POLICY No R2 DRUG TESTING Summary of Changes MEDICAL POLICY DRUG TESTING Effective Date: April 10, 2017 Review Dates: 5/15, 5/16, 11/16, 2/17 Date Of Origin: May 13, 2015 Status: Current Clarifications: Deletions: Additions: Pg.

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides

More information

Forensic Toxicology Scope of Testing and Detection Limits

Forensic Toxicology Scope of Testing and Detection Limits Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2

More information

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories

More information

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50 Clinical Policy: Reference Number: PA.CP.MP.50 Effective Date: 01/18 Last Review Date: 09/17 Coding Implications Revision Log Description Urine drug testing is a key diagnostic and therapeutic tool that

More information

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS Barry K Logan PhD, DABFT National Director of Forensic Services, NMS Labs Willow Grove PA Disclaimer

More information

Testing for Controlled Substances

Testing for Controlled Substances Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug

More information

Procedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager

Procedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting drug testing results. 2.0 Scope This procedure applies to all submissions

More information

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens This document describes the validation of a Neogen Fentanyl kit for the semi-quantitative analysis of

More information

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND ERKKI VUORI 12.-13.11.2012 HJELT INSTITUUTTI OIKEUSLÄÄKETIETEEN OSASTO FINLAND IS AN IDEAL COUNTRY FOR POST- MORTEM TOXICOLOGICAL INVESTIGATIONS High autopsy

More information

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD. Applications of High Resolution Mass Spectrometry in Forensic Toxicology Patrick Kyle, PhD pkyle@umc.edu Financial Disclosures Grant/Research Support: None Salary/Consultant Fees: None Board/Committee/Advisory

More information

Procedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis

Procedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting the results of the analysis. 2.0 Scope This procedure applies to all

More information

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences 12/13/2018 WELCOME! Today s Topic: Urine Drug Screens in OUD Treatment Should I test and how should I do drug testing

More information

2017 Drug Screen Tests

2017 Drug Screen Tests 2017 Drug Screen Tests The ABCs of Applying the CMS 2017 HCPCS Codes Written by: Karen D. Chappell, EJD, MBA, CIRCC, CPMA, CPC-I, CHC Terminology Immunoassay Qualitative Therapeutic Quantitative GC/MS

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J. Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED

More information

Drug Screening: Things You Need to Know

Drug Screening: Things You Need to Know Drug Screening: Things You Need to Know (a view inside the clinical laboratory) Gary L. Horowitz, MD Director, Clinical Chemistry, Beth Israel Deaconess Medical Center Associate Professor of Pathology,

More information

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty

More information

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and

More information

Urine Drug Screening: The Essentials of Interpretation

Urine Drug Screening: The Essentials of Interpretation Urine Drug Screening: The Essentials of Interpretation Loralie J Langman, PhD DABCC (CC, MD, TC), F-ABFT Director Clinical and Forensic Toxicology Laboratory, Mayo Clinic Professor, Mayo Clinic College

More information

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D. Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals

More information

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Brian Simons, Forensic Toxicologist Montgomery County Coroner s Office / Miami Valley Regional Crime Laboratory May 1, 2008

More information

Pain Management Drug Testing: A Laboratory Perspective

Pain Management Drug Testing: A Laboratory Perspective Ernest Jimenez III, M.T.(ASCP) Nothing to declare. Laboratory manager at Pharos Diagnostics, LLC., located in Tucson, AZ. Pain Management Drug Testing: A Laboratory Perspective 1 2 Pain Management Drug

More information

Fentanyl Postmortem Redistribution: Preliminary Findings Regarding the Relationship Among Femoral Blood and Liver and Heart Tissue Concentrations

Fentanyl Postmortem Redistribution: Preliminary Findings Regarding the Relationship Among Femoral Blood and Liver and Heart Tissue Concentrations Fentanyl Postmortem Redistribution: Preliminary Findings Regarding the Relationship Among Femoral Blood and Liver and Heart Tissue Concentrations Kristin Luckenbill 1,2, Jonathan Thompson 3, Owen Middleton

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008 INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 28 A report from the Office of Epidemiology and Planning Baltimore City Health Department

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Urine Drug/Alcohol Screening and Testing PUM 250-0013-1803 Medical Policy Committee Approval 03/06/18 Effective Date 07/01/18 Prior Authorization Needed No Disclaimer: This

More information

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50 Clinical Policy: Reference Number: PA.CP.MP.50 Effective Date: 01/18 Last Review Date: 09/18 Coding Implications Revision Log Description Urine drug testing is a key diagnostic and therapeutic tool that

More information

Drug Profiles of Apprehended Drivers in Victoria

Drug Profiles of Apprehended Drivers in Victoria Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83

More information

PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN

PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN PROJECT ECHO OPIOID USE DISORDER IN PREGNANT WOMEN 1 OPIOID USE DISORDER IN WOMEN Recognition & Prevention Date: August 14 th, Time: 8 am Presenters: Deepa Nagar MD, Andria Peterson PharmD Maternal Treatment

More information

Tests recently added to the NMS Labs test menu. New Tests are effective immediately.

Tests recently added to the NMS Labs test menu. New Tests are effective immediately. Immediate Action In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed

More information

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082 Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending

More information

Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS

Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS Mike Frontz, Robert Rodriguez, Gary Kunsman Bexar County Medical Examiner s Office, San Antonio, TX Brad Hall, Patricia Schroeder,

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

Pain Medication Management Program Supports Patient Outcomes and Adherence

Pain Medication Management Program Supports Patient Outcomes and Adherence PeaceHealth Laboratories UPDATE 2015 Revised Edition Pain Medication Management Program Supports Patient Outcomes and Adherence BENEFITS Monitors analgesic medication adherence to ensure patient safety

More information

Disclosures. You're in Control or Urine Control Clinical Pearls of Drug Testing Case Studies. 9/20/17

Disclosures. You're in Control or Urine Control Clinical Pearls of Drug Testing Case Studies.   9/20/17 You're in Control or Urine Control Clinical Pearls of Drug Testing Case Studies Jeffrey Fudin, BS, PharmD, FCCP, FASHP www.paindr.com Disclosures Astra Zeneca (Speakers Bureau) Collegium (Consultant) Daiichi

More information

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem Objectives Discuss the recent spread of opioid misuse Discuss the rise of the current opioid crisis, a national addiction/overdose problem Includes medical and illicit opioids Objectives Discuss the dangers

More information

Laboratory Service Report

Laboratory Service Report 4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric

More information

TRIM reference DD17/ Endorsed by Publication date Review date

TRIM reference DD17/ Endorsed by Publication date Review date Participant procedure: drug Procedures provide practical step by step guidance to describe processes and actions required to enable the implementation of a policy or guideline. They can also be developed

More information

Urine drug testing it s not always crystal clear

Urine drug testing it s not always crystal clear Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine

More information

Pain Medication Management Program Monitors Patient Compliance

Pain Medication Management Program Monitors Patient Compliance PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your

More information

A substance that reduces pain and may or may not have psychoactive properties.

A substance that reduces pain and may or may not have psychoactive properties. GLOSSARY OF TERMS AMPHETAMINE-TYPE STIMULANTS (ATS) A group of substances, mostly synthetic, with closely related chemical structure which have, to varying degrees, a stimulating effect on the central

More information

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine?

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine? Gold Standard for Urine Drug Testing Developed by TRMC Pain Management Center Jill Duffy, RN,BC Pam Kennell, RN, BC Heidi Beisch, RN Urine Drug Testing A DIAGNOSTIC tool For an OBJECTIVE test Based on

More information

Powering Efficient Behavioral Health Care Services

Powering Efficient Behavioral Health Care Services Powering Efficient Behavioral Health Care Services Streamlining behavioral health care decisions through comprehensive and efficient drug monitoring Quest Diagnostics has you and your patients covered

More information

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Payment Policy: Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Coding Implications Revision Log See Important Reminder at the end of this policy for important

More information

Drug Testing Index. A comprehensive analysis of workplace drug use trends

Drug Testing Index. A comprehensive analysis of workplace drug use trends Drug Testing Index A comprehensive analysis of workplace drug use trends Employer Solutions Annual Report Fall 2016 Table of contents Analysis Drug Positivity in U.S. Workforce Rises to Highest Level in

More information

Guidelines on Autopsy Practice: Scenario 3: Suspected illicit drugs

Guidelines on Autopsy Practice: Scenario 3: Suspected illicit drugs Guidelines on Autopsy Practice: Scenario 3: Suspected illicit drugs Updates made August 2005 1. Pathology encountered: causes of death re-ordered, with addition of chronic alcohol ketoalcoholic syndrome

More information

Clearing Up The Confusion About Substance Abuse Testing

Clearing Up The Confusion About Substance Abuse Testing Clearing Up The Confusion About Substance Abuse Testing 2018 Indiana Safety and Health Conference and Expo Presented by Tiffany Ellefson, DISA/Midwest Toxicology Services Items to cover Latest Trends in

More information

April 28, RE: Immediate Action test change notification. Dear Valued Client:

April 28, RE: Immediate Action test change notification. Dear Valued Client: April 28, 2010 RE: Immediate Action test change notification Dear Valued Client: The following pages detail important information regarding a test requiring database modifications. Please be advised that

More information

Illicit Opioid and Methamphetamine Trends in Maine

Illicit Opioid and Methamphetamine Trends in Maine Illicit Opioid and Methamphetamine Trends in Maine Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine Objectives Provide an overview of the illicit opioid crisis in Maine, focusing

More information

Substance abuse is a significant problem in the United

Substance abuse is a significant problem in the United Interpretation and Utility of Drug of Abuse Immunoassays Lessons From Laboratory Drug Testing Surveys Stacy E. F. Melanson, MD, PhD; Leland Baskin, MD; Barbarajean Magnani, PhD, MD; Tai C. Kwong, PhD;

More information

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE

More information

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure

More information

Flakka : The Truth Behind the Latest Designer Drug Media Storm. Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs

Flakka : The Truth Behind the Latest Designer Drug Media Storm. Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs Flakka : The Truth Behind the Latest Designer Drug Media Storm Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs Flakka Flakka Headlines What is Flakka? Flakka = Spanish slang for thin, pretty

More information

The Latest Prescription Trends for Controlled Prescription Drugs

The Latest Prescription Trends for Controlled Prescription Drugs The Latest Prescription Trends for Controlled Prescription Drugs September 1, 2015 Christopher M. Jones PharmD, MPH Senior Advisor Office of Public Health Strategy and Analysis Office of the Commissioner

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG

More information

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation

More information

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry.

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Dr Tim Laurens MSc.Chem(Pretoria), Ph.D. Chem (Pretoria), MSc.Toxicology (Surrey,UK) FRSChem, MFSSoc Email: laurensj@lancet.co.za / tim.laurens@up.ac.za

More information

Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective

Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective Article in press - uncorrected proof Clin Chem Lab Med 2009;47(8):971 976 2009 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2009.220 2009/180 Analysis and interpretation of drug testing results

More information

Quest Diagnostics Drug Testing Index Full Year 2015 Tables

Quest Diagnostics Drug Testing Index Full Year 2015 Tables Quest Diagnostics Drug Testing Index Full Year 2015 Tables Table 1. Annual Positivity Rates Urine Drug Tests (For Combined U.S. Workforce) (More than 9.5 million tests from January to December 2015) Year

More information

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation

More information

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Jay Butler, MD, President of ASTHO, Chief Medical Officer, Alaska Department of Health

More information

Fentanyl and Synthetic Opioids- Awareness and the Enforcement Pillar. July-16-18

Fentanyl and Synthetic Opioids- Awareness and the Enforcement Pillar. July-16-18 Fentanyl and Synthetic Opioids- Awareness and the Enforcement Pillar Opioid Situation-How we got here 2012 Oxycontin moves to the tamper proof version OxyNeo (Purdue Pharma) 2012/2013 Patch diversion and

More information

NeoSal Oral Fluid Collection System Solutions for Forensic Drug Detection

NeoSal Oral Fluid Collection System Solutions for Forensic Drug Detection PERFORMANCE OF THE NEOSAL ORAL FLUID COLLECTION SYSTEM Neogen develops and manufactures a comprehensive range of ELISA test kits and accessories for forensic drug detection. Neogen offers solutions to

More information

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D.

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D. Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva Edward J. Cone, Ph.D. Johns Hopkins School of Medicine, Baltimore, MD & ConeChem Research,

More information

DRUG AND ALCOHOL-FREE AUC PROPERTY POLICY

DRUG AND ALCOHOL-FREE AUC PROPERTY POLICY DRUG AND ALCOHOL-FREE AUC PROPERTY POLICY Policy Statement In accordance with Egyptian and US law, the University has adopted a drug and alcohol-free AUC property policy. All University students are required

More information

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Test Definition: PCDSO Pain Clinic Drug Screen, Urine Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle

More information

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith There is something in the heroin: responding to a rise in drug related deaths and the emergence of fentanyl and carfentanil in a local illicit drug market Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony

More information

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent? Objectives Drug Testing Interpretation in Addiction Care Brandi Puet, Pharm.D. Describe the difference between immunoassay and confirmatory testing. List explanations for unexpected negative or positive

More information

Toxicology aspects of SUDI. Dr Stephen Morley STH

Toxicology aspects of SUDI. Dr Stephen Morley STH Toxicology aspects of SUDI Dr Stephen Morley STH Epidemiology of SUDI toxicology Neonatal-placental transfer Breast milk 3 rd person administration Association between illicit drug use in pregnancy and

More information

B. To assess an individual when clinical evaluation suggests use of non-prescribed medications or illegal substances; or

B. To assess an individual when clinical evaluation suggests use of non-prescribed medications or illegal substances; or Integrated Reference #: MP/D010 Page: 1 of 7 PRODUCT APPLICATION: PreferredOne Community Health Plan (PCHP) PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services,

More information

You Can t Fool the Bladder Police. Effective Use of Urine Drug Screening

You Can t Fool the Bladder Police. Effective Use of Urine Drug Screening You Can t Fool the Bladder Police Effective Use of Urine Drug Screening Why Test? Accountability Create and maintain safe treatment environment Compliance with licensing or policy Collection Supervised

More information

THE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE

THE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE THE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE T. Varga 1, M. Vali 2, R. Wachowiak 3, F. Longauer 4, M. Zorec-Karlovsek 5 1. Dept. of Forensic Medicine, University of Szeged,

More information

Rapid Alcohol Screening Devices. p19

Rapid Alcohol Screening Devices. p19 CLIA-WAIVED Product Catalog RAPID DRUG SCREENING DEVICES Rapid Urine Drug Screening Devices. p5 Rapid Alcohol Screening Devices. p19 Complementary Products. p23 HELPING YOU MAKE INFORMED DECISIONS ABOUT

More information

Rising Threats in the Nation s Drug Epidemic

Rising Threats in the Nation s Drug Epidemic WiFi: CWAGNM No Password Rising Threats in the Nation s Drug Epidemic Michael E. Prevoznik Senior Vice President and General Counsel Conference of Western Attorneys General Annual Meeting July 2018 2 An

More information

A Review of the Methods, Interpretation, and Limitations of the Urine Drug Screen

A Review of the Methods, Interpretation, and Limitations of the Urine Drug Screen Section Editor: Kelly M. Smith, PharmD, BCPS, FASHP, FCCP A Review of the Methods, Interpretation, and Limitations of the Urine Drug Screen E. Claire Markway, PharmD; Stephanie N. Baker, PharmD, BCPS Abstract:

More information

Clinical Policy: Outpatient Testing for Drugs of Abuse

Clinical Policy: Outpatient Testing for Drugs of Abuse Clinical Policy: Reference Number: CP.MP.50 Last Review Date: 07/18 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications Revision Log Description

More information

Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients

Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients Gwen McMillin, PhD, DABCC(CC,TC) Professor, University of Utah Medical Director,

More information

NURSING INTAKE. Provider Name: Provider Signature: Nursing Summary. Are you pregnant at this time?

NURSING INTAKE. Provider Name: Provider Signature: Nursing Summary. Are you pregnant at this time? NURSING INTAKE Provider Name: Provider Signature: Date: Nursing Summary Are you pregnant at this time? 3 = Don t know 4 = Tubal ligation 5 = Menopause 6 = History of hysterectomy 7 = Other: 8 = N/A patient

More information

The Utility of Urine Drug Screening

The Utility of Urine Drug Screening The Utility of Urine Drug Screening Treating Addiction, Saving Lives Sea Cruises Bye Tazmania, still far from New Zealand February 8 th, 2018 Mandy Manak, MD FASAM, ISAM, CSAM, MRO Medical Director, ICDO

More information

Can adderall cause a false positive on a drug test

Can adderall cause a false positive on a drug test Can adderall cause a false positive on a drug test The Borg System is 100 % Can adderall cause a false positive on a drug test If you're about to take a drug test, watch out if you are taking one of these

More information

DRUG OVERDOSE DEATHS ANALYSIS

DRUG OVERDOSE DEATHS ANALYSIS Overview CUYAHOGA COUNTY MEDICAL EXAMINER DRUG OVERDOSE DEATHS ANALYSIS Analysis of Fentanyl-Related Overdose Deaths in Cleveland/Cuyahoga County, Ohio in 2014 April 2015 The Cuyahoga County Medical Examiner

More information